| Popis: |
Liquid biopsy (LB) represents an important tool for modern oncology that enables increasingly safe, personalized, and robust cancer diagnosis and treatment. State-of-the-art LB systems require the amplification of the DNA in the blood samples, a cost and time-consuming process. Using low light level photosensors and arrival timing information, we aim with PHIL to avoid the amplification stage which would be a breakthrough in the field of molecular diagnostic in oncology. In this article, we summarize our achievements during the project and our future vision. |
